Investing in Exceptional Women-Led Growth Businesses

Has been our business since 1998
*

The average woman-owned business makes 20% more revenue
with 50% less investment than other companies.

Imagine what the above-average can do.

We’re Sofia Fund. And we find, invest in and grow those exceptional women-led companies.

We work side-by-side with our entrepreneurs, connecting them with resources and
taking
them – and our co-investors – to profitable exits.   

As business owners, we understand what it takes to build a successful company.
And we’ve invested more than $10 million in over 50 companies.

You could say we’re no ordinary angels. 

We go beyond achieving parity for women entrepreneurs
by releasing their tremendous financial opportunity.

We are Sofia Fund.

If you are a woman led team with a compelling business
or a co-investor interested in our portfolio, join us.
  

Focus

Gender-diverse teams with disruptive, scalable business models that use technology to solve real problems. Demonstrated validation of the value proposition is important. Interested in businesses where our investment can be leveraged by the additional resources and support Sofia can bring to foster success. Particular areas of interest are:

  • Woman Working on Futuristic Screen
    Information Technology and Managed Services

    Information Technology: 

    Two of our managing partners have extensive experience as operators and investors in a variety of information technology businesses, including those that employ software, hardware, apps, analytics, IoT and/or AI technology and provide transformative, value-added outcomes for businesses and consumers.

  • Businesswoman Using a Smartphone
    Business Products and Services

    Business Products and Services: 

    One of our managing partners has been a serial entrepreneur in this space.  Another has lengthy experience with a wide variety of technology innovations that will enhance business processes and operations.

  • Technology Investments
    Technology

    Technology:  

    Technologies that provide value to businesses and create change — whether it be materials-based, green-focused, IoT, or new electronic capabilities. All are of interest.  

  • Stethoscope on a Computer
    Health and Wellness

    Health and Wellness: 

    Technology (materials, IT, analytics) applied to the health and wellness market space is an area in which we are very interested and involved.  Our networks and resources in the health and wellness space are extensive.

  • Woman Working on Futuristic Screen
    Information Technology and Managed Services

    Information Technology: 

    Two of our managing partners have extensive experience as operators and investors in a variety of information technology businesses, including those that employ software, hardware, apps, analytics, IoT and/or AI technology and provide transformative, value-added outcomes for businesses and consumers.

  • Businesswoman Using a Smartphone
    Business Products and Services

    Business Products and Services: 

    One of our managing partners has been a serial entrepreneur in this space.  Another has lengthy experience with a wide variety of technology innovations that will enhance business processes and operations.

  • Technology Investments
    Technology

    Technology:  

    Technologies that provide value to businesses and create change — whether it be materials-based, green-focused, IoT, or new electronic capabilities. All are of interest.  

  • Stethoscope on a Computer
    Health and Wellness

    Health and Wellness: 

    Technology (materials, IT, analytics) applied to the health and wellness market space is an area in which we are very interested and involved.  Our networks and resources in the health and wellness space are extensive.

Investment Criteria

 Sofia Fund is interested in companies with:

  • Excellent, experienced management team
  • Scalable business model
  • Proprietary positioning
  • Growing, large markets
  • Well-defined, demonstrable business model with proof of concept revenue
  • Future exit that can be leverage with Sofia’s network and resources

Typical investments by Sofia are from $100,000-$500,000 in $500,000-$2 million rounds of equity. We are looking for opportunities where ideally there are no more than 2-3 subsequent funding rounds and exits are within 3-5 years.   Preferred investment are in the form of preferred stock in C corporations.

Sofia Application Process:

Companies should apply directly to Sofia Fund using the application link on this site.  We are currently investing from Sofia Angel Fund II, LLC.

Deals are reviewed regularly by the screening committee and interest will be communicated. Deals of interest will be asked to present to the Sofia Fund managing partners, which will be followed by due diligence, if appropriate. 

Team

Managing Partners

  • Cathy Connett
  • Lisa Crump
  • Joy Lindsay
  • Dee Thibodeau - Investor
    Dee Thibodeau

Fund Advisory Board

  • Deb Bauman, Advisor
  • Brigid Bonner, Advisor
  • Jeannine Rivet, Advisor
  • Barbara Stinnett - Investor
    Barb Stinnett, Advisor

Current Women-Led Portfolio Companies

Since 1998, Sofia Fund and its managing partners have invested more than $10M in over 50 companies.

  • Sofia Fund II

    Focuses on the development of small molecule therapeutics targeting the toxic proteins that cause Alzheimer’s.

    More about Cognition Therapeutics

  • Sofia Fund II

    Joylux creates innovative health solutions targeting the enormous, but underserved female intimate care market with in home, consumer products such as VFit.

    More about Joylux

  • Sofia Fund II

    A marketplace platform that provides a storefront for moms to buy and sell the latest styles for their kids and builds a vibrant community that connects moms with other moms through shared experiences and a shared sense of style.

    More About Kidizen

  • Sofia Fund II

    A technology platform created to increase the success and engagement of women in the workplace, and to enable enterprises to attract, develop, and retain high-potential diverse talent.

    More About Landit

  • Sofia Fund I

    A girls’ magazine and online communities of girls, parents, and allies helping girls find their voice and resources to help them cope with the challenges of growing up in today’s world.

    More about New Moon Girls Media

  • Sofia Fund II

    Developing leading-edge technology to transform traumatic brain injury diagnosis, bring personalized medicine to concussion diagnosis and treatment, and improve outcomes for the millions of people who annually suffer TBI and concussion.

    More about Oculogica

  • Sofia Fund I

    Vixar manufactures both standard and custom designed short wavelength (660nm to 1000nm) VCSEL-based optical components and subassemblies for sensor and device applications within the biomedical, industrial, office product, automative and consumer industries.

    More about Vixar

  • Sofia Fund II

    Focuses on the development of small molecule therapeutics targeting the toxic proteins that cause Alzheimer’s.

    More about Cognition Therapeutics

  • Sofia Fund II

    Joylux creates innovative health solutions targeting the enormous, but underserved female intimate care market with in home, consumer products such as VFit.

    More about Joylux

  • Sofia Fund II

    A marketplace platform that provides a storefront for moms to buy and sell the latest styles for their kids and builds a vibrant community that connects moms with other moms through shared experiences and a shared sense of style.

    More About Kidizen

  • Sofia Fund II

    A technology platform created to increase the success and engagement of women in the workplace, and to enable enterprises to attract, develop, and retain high-potential diverse talent.

    More About Landit

  • Sofia Fund I

    A girls’ magazine and online communities of girls, parents, and allies helping girls find their voice and resources to help them cope with the challenges of growing up in today’s world.

    More about New Moon Girls Media

  • Sofia Fund II

    Developing leading-edge technology to transform traumatic brain injury diagnosis, bring personalized medicine to concussion diagnosis and treatment, and improve outcomes for the millions of people who annually suffer TBI and concussion.

    More about Oculogica

  • Sofia Fund I

    Vixar manufactures both standard and custom designed short wavelength (660nm to 1000nm) VCSEL-based optical components and subassemblies for sensor and device applications within the biomedical, industrial, office product, automative and consumer industries.

    More about Vixar

Exited Women-Led Companies

  • Sensor-based equipment for the aerospace, environmental and process control markets.

    Acquired by Ecolab.

     

  • Trusted experts in sun safety, Coolibar designs, manufactures, and markets sun protection clothing.

    Acquired.

  • Life science tools focused on the area of nucleic acid purification products.

    Acquired by Qiagen.

  • Consumer research and advisory firm that provides consumer trend and market research services.

    Acquired by CEB.

     

  • Technology-based strategy and marketing firm aligned with Salesforce.com.

    Acquired by Mindtree.

     

  • A clinical stage biotechnology company revolutionizing the treatment of debilitating gastrointestinal (GI) diseases by harnessing the power of the human microbiome. Rebiotix develops standarized and stabilized, regulated drug products that restore the gut microbiota.

    Acquired by Ferring Pharmaceuticals

  • Provides clinically proven, at-home treatment options for lymphedema and chronic venooous insufficiency with continuity of care, service, support that helps improve outcomes, reduce costs and gives people their lives back.

    IPO

  • Data storage solutions.

    Acquired by Seagate.

  • Sensor-based equipment for the aerospace, environmental and process control markets.

    Acquired by Ecolab.

     

  • Trusted experts in sun safety, Coolibar designs, manufactures, and markets sun protection clothing.

    Acquired.

  • Life science tools focused on the area of nucleic acid purification products.

    Acquired by Qiagen.

  • Consumer research and advisory firm that provides consumer trend and market research services.

    Acquired by CEB.

     

  • Technology-based strategy and marketing firm aligned with Salesforce.com.

    Acquired by Mindtree.

     

  • A clinical stage biotechnology company revolutionizing the treatment of debilitating gastrointestinal (GI) diseases by harnessing the power of the human microbiome. Rebiotix develops standarized and stabilized, regulated drug products that restore the gut microbiota.

    Acquired by Ferring Pharmaceuticals

  • Provides clinically proven, at-home treatment options for lymphedema and chronic venooous insufficiency with continuity of care, service, support that helps improve outcomes, reduce costs and gives people their lives back.

    IPO

  • Data storage solutions.

    Acquired by Seagate.

Resources

ACAMemberLogo-forWeb

MNCup

News

SOFIA FUND ACHIEVES SUCCESSFUL EXIT

SOFIA FUND ACHIEVES SUCCESSFUL EXIT Technology Company Vixar Acquired by Semiconductor Leader Osram JULY 31, 2018 (Minneapolis) — Sofia Fund, a leading angel investment firm focused on high-growth women-led technology based early stage companies, today announced that its portfolio company, technology company Vixar Inc., has been acquired by Osram Semiconductor, a unit of Osram, a German-based lighting technology company. Vixar develops VCSELs (a form of lasers) for use in a variety of products in medical, industrial and automotive applications. One the most well-known VSCEL applications is for enhancing user identification by mobile devices. Vixar was founded in 2005 by pioneers in VSCEL technology who brought its use to the data communications market in the late 1990s and more recently to sensing applications. Vixar has approximately 20 employees at its offices in Plymouth, Minnesota. Sofia Fund invested in Vixar through its first investment fund, Sofia Angel Fund, LLC. Vixar’s acquisition is the fourth successful exit from that fund, which started investing in 2007 and now has three companies remaining in its original portfolio of nine companies. “Vixar is an exceptional women-led company that had great potential for investors to realize a successful return,” said Cathy Connett, CEO and a managing partner of Sofia Fund. “The founders recognized the opportunity to take their research out of a larger organization, in this case Honeywell, and continue to diligently develop it into the market of consumers, who are now ready for the incorporation of VSCEL technology into their everyday lives – from applications such as the back-up camera on their car to having their cell phone recognize their face.” “Our years of investing...

Sofia Fund Focus on Women-Led Firms

Interview with Neal St Anthony of the Star Tribune brings visibility to Sofia Fund and its partners’ long and successful involvement in investing in women led companies. Sofia Fund Partners Maintain Their Focus on Women-Led...

Looking Concussion in the Eye

A recent post in the April/ May Issue of MIT Review discusses the science Uzma Samadani used as she sought to find a way to measure improvements in her severely, brain-injured patients.   The ability to capture a large amount of data from tracking not only eye movement but restrictions on range of motion in the eye led to the EyeBox product being developed by Oculogica, one of Sofia Fund’s portfolio companies.   Eye tracking has been used for centuries but measuring and interpreting the restrictions on the range of motion without a baseline measurement is helping take the guesswork out of  diagnosing and tracking improvements in concussed patients.   See more at  Looking Concussion in the Eye...

Apply

Companies should apply directly to Sofia Angel Fund II by clicking the button in this section.

Contact

Email Us  • Phone 651.699.9614
Sofia logo-gry